Alembic Pharmaceuticals has released its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, prepared by independent practicing company secretaries, confirms that the company has maintained adherence to mandatory governance standards and disclosure requirements. The review highlights that the organization has successfully upheld transparency and operational compliance throughout the period, ensuring all necessary governance protocols were met without any noted deviations or violations.
Compliance Performance Overview
The annual audit for the fiscal year concluded on March 31, 2026, focused on the company’s adherence to various corporate governance mandates and operational guidelines. The comprehensive review process involved a thorough examination of internal filings, website disclosures, and overall corporate submissions. The assessment concluded that the company is fully compliant with all governing standards, maintaining a clean record without any instances of non-compliance or identified violations.
Governance and Operational Highlights
The review encompassed key areas of corporate management, confirming that all board-approved policies remain current and aligned with industry standards. Key highlights from the report include:
- Policy Adherence: All company policies are effectively adopted and updated in a timely manner.
- Website Transparency: The company maintains a fully functional and transparent website with timely disclosures.
- Director Standards: All members of the board meet the required eligibility and qualification criteria.
- Performance Evaluation: Structured performance evaluations for the Board, its committees, and independent directors were completed as scheduled.
Integrity of Financial Governance
The assessment further verified that the company remains diligent in preserving records and managing documentation according to prescribed archival policies. Furthermore, the company has demonstrated robust management of related-party transactions and prompt disclosure of all significant events. The audit process provides assurance that the management has conducted the company’s affairs with high standards of efficacy and transparency during the 2026 fiscal year.
Source: BSE
